Literature DB >> 21127342

Comparative analyses of differentially induced T-cell receptor-mediated phosphorylation pathways in T lymphoma cells.

Serina Ortiz1, Wenhui Lee, David Smith, Stephen J Forman, Terry D Lee, Chih-Pin Liu.   

Abstract

Activation of T lymphoma cells expressing Syk, but not ZAP-70 tyrosine kinase, has been shown to negatively regulate cell activation and activation-induced cell death (AICD), perhaps due to differential induction of tyrosine phosphorylation modified proteins. To better understand the role of these proteins and their associated molecules/pathways, we studied a previously described model of T lymphoma cells expressing either a kinase-activated chimeric Syk or ZAP-70 genetically linked to T-cell receptor (TCR) ζ chain (Z/Syk or Z/ZAP cells, respectively). To help identify molecules and pathways linked to cell activation or AICD, a comparative semi-quantitative proteomics-based approach was utilized to analyze tyrosine-phosphorylated protein immunoprecipitates from two-minute short-term activated Z/Syk or Z/ZAP cells. Using the resulting bioinformatics data-sets, we identified several differentially immunoprecipitated proteins that could be validated biochemically. More tyrosine-phosphorylated and phosphotyrosine-associated proteins were found in Z/Syk than in Z/ZAP cells. Proteins involved in different unique functional pathways were induced in these cells and showed altered intermolecular interactions in varied pathways. Remarkably, 41% of differentially identified proteins in Z/Syk cells belonged to cell cycle or vesicle/trafficking pathways. In contrast, 21% of such proteins in Z/ZAP cells belonged to metabolism pathways. Therefore, molecular pathways involved in post-translational modifications linked to distinct cellular/physiological functions are differentially activated, which may contribute to varied activation and AICD responses of these cells. In summary, we identified proteins belonging to novel differentially activated pathways involved in TCR-mediated signaling, which may be targets for regulating activation and AICD of T lymphoma cells and for potential cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21127342      PMCID: PMC3247199          DOI: 10.1258/ebm.2010.010056

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  40 in total

1.  Role of the cytokine-induced SH2 domain-containing protein CIS in growth hormone receptor internalization.

Authors:  Tanya Landsman; David J Waxman
Journal:  J Biol Chem       Date:  2005-09-08       Impact factor: 5.157

Review 2.  Absolute quantification strategies in proteomics based on mass spectrometry.

Authors:  Mark Brönstrup
Journal:  Expert Rev Proteomics       Date:  2004-12       Impact factor: 3.940

3.  Comparison of label-free methods for quantifying human proteins by shotgun proteomics.

Authors:  William M Old; Karen Meyer-Arendt; Lauren Aveline-Wolf; Kevin G Pierce; Alex Mendoza; Joel R Sevinsky; Katheryn A Resing; Natalie G Ahn
Journal:  Mol Cell Proteomics       Date:  2005-06-23       Impact factor: 5.911

Review 4.  Proteasome-independent functions of ubiquitin in endocytosis and signaling.

Authors:  Debdyuti Mukhopadhyay; Howard Riezman
Journal:  Science       Date:  2007-01-12       Impact factor: 47.728

Review 5.  Tumor suppressors: control of signaling by endocytosis.

Authors:  Bernd Giebel; Andreas Wodarz
Journal:  Curr Biol       Date:  2006-02-07       Impact factor: 10.834

Review 6.  Proteome analysis in the clinical chemistry laboratory: myth or reality?

Authors:  Pier Giorgio Righetti; Annalisa Castagna; Francesca Antonucci; Chiara Piubelli; Daniela Cecconi; Natascia Campostrini; Chiara Rustichelli; Paolo Antonioli; Gianluigi Zanusso; Salvatore Monaco; Lee Lomas; Egisto Boschetti
Journal:  Clin Chim Acta       Date:  2005-07-24       Impact factor: 3.786

7.  Detecting differential and correlated protein expression in label-free shotgun proteomics.

Authors:  Bing Zhang; Nathan C VerBerkmoes; Michael A Langston; Edward Uberbacher; Robert L Hettich; Nagiza F Samatova
Journal:  J Proteome Res       Date:  2006-11       Impact factor: 4.466

8.  A new tyrosine phosphorylation site in PLC gamma 1: the role of tyrosine 775 in immune receptor signaling.

Authors:  Carmen J Serrano; Laurie Graham; Karen DeBell; Rashmi Rawat; Maria Concetta Veri; Ezio Bonvini; Barbara L Rellahan; Ilona G Reischl
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

9.  Engaged and bystander T cell receptors are down-modulated by different endocytotic pathways.

Authors:  Alicia Monjas; Andrés Alcover; Balbino Alarcón
Journal:  J Biol Chem       Date:  2004-10-28       Impact factor: 5.157

Review 10.  Met receptor dynamics and signalling.

Authors:  D E Hammond; S Carter; M J Clague
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

View more
  4 in total

1.  Inhibition of S-phase kinase-associated protein 2 (Skp2) reprograms and converts diabetogenic T cells to Foxp3+ regulatory T cells.

Authors:  Ding Wang; Hanjun Qin; Weiting Du; Yueh-Wei Shen; Wen-Hui Lee; Arthur D Riggs; Chih-Pin Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

Review 2.  T-cell receptor signaling in peripheral T-cell lymphoma - a review of patterns of alterations in a central growth regulatory pathway.

Authors:  Kathrin Warner; Nicole Weit; Giuliano Crispatzu; Joan Admirand; Dan Jones; Marco Herling
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

3.  SYK expression in monomorphic epitheliotropic intestinal T-cell lymphoma.

Authors:  Grit Mutzbauer; Katja Maurus; Clara Buszello; Jordan Pischimarov; Sabine Roth; Andreas Rosenwald; Andreas Chott; Eva Geissinger
Journal:  Mod Pathol       Date:  2017-10-20       Impact factor: 8.209

4.  Nanoscale Relationship Between CD4 and CD25 of T Cells Visualized with NSOM/QD-Based Dual-Color Imaging System.

Authors:  Jinping Fan; Xiaoxu Lu; Shengde Liu; Liyun Zhong
Journal:  Nanoscale Res Lett       Date:  2015-10-26       Impact factor: 4.703

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.